ViAqua Therapeutics, a biotechnology company and developer of an orally administered RNA-particle platform to promote and improve animal health in aquaculture, has completed a $4.3 million round to commercialize and expand its platform. [...]
Want to keep reading?
Sign up for a trial to have full access to our articles for 7 days!
Have an account? Log in here:
Enter the email address associated with your account. We'll send you instructions to reset your password.
We’ve sent a link to to change your password.
Please check your inbox to reset your password securely and easily.
redirecting...
